by European Food Safety Authority (EFSA) (2014) Abstract Following an application from InQpharm Europe Ltd, submitted for authorization of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of the United Kingdom, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to a standardized aqueous extract from white kidney bean (Phaseolus vulgaris L.) and reduction of body weight. The Panel considers that the food is sufficiently characterized. A reduction in body weight is a beneficial physiological effect for overweight individuals. The applicant identified a total of four human intervention studies which investigated the effects of the aqueous extract from white kidney bean on body weight as being pertinent to the claim. No conclusions could be drawn from two of these four studies. In weighing the evidence, the Panel took into account that one human intervention study showed an effect of the standardised aqueous extract from white kidney bean in reducing body weight when consumed for 12 weeks, that the reduction in body weight was mostly through a reduction in body fat and that the effect of the standardized aqueous extract from white kidney bean on body weight was supported by a second study of shorter duration. However, the Panel also took into account that the first study was at risk of bias, that the supportive study suffered from methodological limitations and that no evidence was provided for a mechanism by which the standardized aqueous extract from white kidney bean could exert the claimed effect. The Panel concludes that the evidence provided is insufficient to establish a cause and effect relationship between the consumption of the standardized aqueous extract from white kidney bean (Phaseolus vulgaris L.) and reduction of body weight. For the full study, click here. The post Scientific Opinion on the substantiation of a health claim related to a standardized aqueous extract from white kidney bean appeared first on Slovakia.
by European Food Safety Authority (EFSA) (2010) Summary Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 o
prejsť na článokby European Food Safety Authority (EFSA) European Food Safety Authority (EFSA) health claim: Contributes to bodyweight management. Contributes to lipid degradation. Helps maintain healthy body weight. For a list of sources, click here. The post EFSA Clai
prejsť na článokby European Food Safety Authority (EFSA) European Food Safety Authority (EFSA) health claim: Contributes to weight reduction. Support in weight loss programs. For a list of sources, click here. The post EFSA Claim: Cayenne Pepper (ID: 2006) appeared first
prejsť na článokby European Food Safety Authority (EFSA) European Food Safety Authority (EFSA) health claim: Contributes to bodyweight management. Contributes to lipid degradation. For a list of sources, click here. The post EFSA Claim: Yerba Mate (ID: 3924) appeared fi
prejsť na článokSyndrómy bielych bodiek (White Dot syndrómy) tvoria skupinu zápalových chorioretinopatií. Hoci White Dot syndrómy zdieľajú mnoho podobných klinických príznakov, vrátane chorioretinálnych lézií, niekoľko odlišných klinických znakov a diagnostických testov
prejsť na článok